Lawes CM, Vander Hoorn S, Law MR, Elliott P, MacMahon S, Rodgers A. Blood pressure and the global burden of disease 2000. Part II: estimates of attributable burden. J Hypertens. 2006;24(3):423–30.
Lawes CMM, Hoorn SV, Rodgers A. Global burden of blood-pressure-related disease. Lancet. 2001;371(9623):1513–8.
Huang Y, Su L, Cai X, Mai W, Wang S, Hu Y, et al. Association of all-cause and cardiovascular mortality with prehypertension: a meta-analysis. Am Heart J. 2014;167(2):160–8. e161.
Huang Y, Cai X, Zhang J, Mai W, Wang S, Hu Y, et al. Prehypertension and Incidence of ESRD: a systematic review and meta-analysis. Am J Kidney Dis. 2014;63(1):76–83.
Huang Y, Cai X, Li Y, Su L, Mai W, Wang S, et al. Prehypertension and the risk of stroke: a meta-analysis. Neurology. 2014;82(13):1153–61.
Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903–13.
MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335(8692):765–74.
Vasan RS, Larson MG, Leip EP, Evans JC, O’Donnell CJ, Kannel WB, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med. 2001;345(18):1291–7.
Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet. 2001;358(9294):1682–6.
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42(6):1206–52.
Qureshi AI, Suri MF, Kirmani JF, Divani AA, Mohammad Y. Is prehypertension a risk factor for cardiovascular diseases? Stroke. 2005;36(9):1859–63.
Shen L, Ma H, Xiang MX, Wang JA. Meta-analysis of cohort studies of baseline prehypertension and risk of coronary heart disease. Am J Cardiol. 2013;112(2):266–71.
Wu S, Huang Z, Yang X, Li S, Zhao H, Ruan C, et al. Cardiovascular events in a prehypertensive Chinese population: four-year follow-up study. Int J Cardiol. 2013;167(5):2196–9.
Huang Y, Wang S, Cai X, Mai W, Hu Y, Tang H, et al. Prehypertension and incidence of cardiovascular disease: a meta-analysis. BMC Med. 2013;11:177.
Kim MJ, Lim NK, Park HY. Relationship between prehypertension and chronic kidney disease in middle-aged people in Korea: the Korean genome and epidemiology study. BMC Public Health. 2012;12:960.
Kanno A, Kikuya M, Ohkubo T, Hashimoto T, Satoh M, Hirose T, et al. Pre-hypertension as a significant predictor of chronic kidney disease in a general population: the Ohasama Study. Nephrol Dial Transplant. 2012;27(8):3218–23.
Middleton JP, Crowley SD. Prehypertension and chronic kidney disease: the ox or the plow? Kidney Int. 2012;81(3):229–32.
Russell LB, Valiyeva E, Carson JL. Effects of prehypertension on admissions and deaths: a simulation. Arch Intern Med. 2004;164(19):2119–24.
Wang Y, Wang QJ. The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: new challenges of the old problem. Arch Intern Med. 2004;164(19):2126–34.
Zhang Y, Lee ET, Devereux RB, Yeh J, Best LG, Fabsitz RR, et al. Prehypertension, diabetes, and cardiovascular disease risk in a population-based sample: the Strong Heart Study. Hypertension. 2006;47(3):410–4.
Mohan V, Deepa M, Farooq S, Datta M, Deepa R. Prevalence, awareness and control of hypertension in Chennai–The Chennai Urban Rural Epidemiology Study (CURES-52). J Assoc Physicians India. 2007;55:326–32.
Yadav S, Boddula R, Genitta G, Bhatia V, Bansal B, Kongara S, et al. Prevalence & risk factors of pre-hypertension & hypertension in an affluent north Indian population. Indian J Med Res. 2008;128(6):712–20.
Erem C, Hacihasanoglu A, Kocak M, Deger O, Topbas M. Prevalence of prehypertension and hypertension and associated risk factors among Turkish adults: Trabzon Hypertension Study. J Public Health (Oxf). 2009;31(1):47–58.
Winegarden CR. From “prehypertension” to hypertension? Additional evidence. Ann Epidemiol. 2005;15(9):720–5.
Giles TD, Berk BC, Black HR, Cohn JN, Kostis JB, Izzo Jr JL, et al. Expanding the definition and classification of hypertension. J Clin Hypertens (Greenwich). 2005;7(9):505–12.
Umemura S. Significance of treating prehypertension with an angiotensin-receptor blocker--results from TROPHY study. Nihon Rinsho. 2008;66(3):601–9.
Bonita R dCM, Dwyer T, Jamrozik K, Winkelmann R. Surveillance of Risk Factors for Noncommunicable Diseases: The WHO STEPwise Approach. Geneva: World Health Organization; 2001.
INDEPTH Network. Population and Health in Developing Countries. Ottawa: INDEPTH Network, IDRC; 2002.
Lindeboom WDS, Ashraf A. Health and Demographic Surveillance Report 2009- Abhoynagar and Mirsarai. Dhaka: International Center for Diarrheal Disease Research; 2011.
Ng N, Van Minh H, Juvekar S, Razzaque A, Huu Bich T, Kanungsukkasem U, et al. Using the INDEPTH HDSS to build capacity for chronic non-communicable disease risk factor surveillance in low and middle-income countries. Glob Health Action. 2009;2:7–18.
Bonita R dCM, Dwyer T, Jamrozik K, Winkelmann R, Armstrong T. Surveillance of Risk Factors for Noncommunicable Diseases: The WHO STEPwise Approach. Geneva: World Health Organization; 2002.
WHO. WHO STEPS Surveillance Manual: The WHO STEPwise Approach to Chronic Disease Risk Factor Surveillance. Geneva: World Health Organization; 2005.
World Health Organization. Global Physical Activity Surveillance. 2009 Available from: http://www.who.int/chp/steps/GPAQ/en/index.html. [cited 16 November 2013].
Razzaque A, Streatfield PK, Gwatkin DR. Does health intervention improve socioeconomic inequalities of neonatal, infant and child mortality? Evidence from Matlab, Bangladesh. Int J Equity Health. 2007;6:4.
Tsai PS, Ke TL, Huang CJ, Tsai JC, Chen PL, Wang SY, et al. Prevalence and determinants of prehypertension status in the Taiwanese general population. J Hypertens. 2005;23(7):1355–60.
Wu Y, Huxley R, Li L, Anna V, Xie G, Yao C, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation. 2008;118(25):2679–86.
Zaman MM, Yoshiike N, Rouf MA, Syeed MH, Khan MR, Haque S, et al. Cardiovascular risk factors: distribution and prevalence in a rural population of Bangladesh. J Cardiovasc Risk. 2001;8(2):103–8.
Lee SH, Kim YS, Sunwoo S, Huh BY. A retrospective cohort study on obesity and hypertension risk among Korean adults. J Korean Med Sci. 2005;20(2):188–95.
Yu D, Huang J, Hu D, Chen J, Cao J, Li J, et al. Prevalence and risk factors of prehypertension among Chinese adults. J Cardiovasc Pharmacol. 2008;52(4):363–8.
Tesfaye F, Nawi NG, Van Minh H, Byass P, Berhane Y, Bonita R, et al. Association between body mass index and blood pressure across three populations in Africa and Asia. J Hum Hypertens. 2007;21(1):28–37.
Koura MR, Al-Dabal BK, Rasheed P, Al-Sowielem LS, Makki SM. Prehypertension among young adult females in Dammam, Saudi Arabia. East Mediterr Health J. 2012;18(7):728–34.
Rahmanian K, Shojaie M. The prevalence of pre-hypertension and its association to established cardiovascular risk factors in south of Iran. BMC Res Notes. 2012;5:386.
Martin JF, Martin LN, Cipullo JP. Pharmacologic treatment for prehypertension: to treat or not to treat? Recent Pat Cardiovasc Drug Discov. 2009;4(2):133–41.
BBS. Statistical Pocket Book of Bangladesh-2008. Dhaka: Bangladesh Bureau of Statistics. Planning division, Ministry of Planning; 2009.